A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial

Peer Review reports

Original Submission
18 Jan 2018	Submitted	Original manuscript
1 Apr 2018	Reviewed	Reviewer Report - S Inogés
4 Apr 2018	Reviewed	Reviewer Report - Robert Fenstermaker
30 Apr 2018	Author responded	Author comments - Marion Rapp
Resubmission - Version 2
30 Apr 2018	Submitted	Manuscript version 2
Publishing
2 May 2018	Editorially accepted
25 May 2018	Article published	10.1186/s13063-018-2659-7

Back to article page